Literature DB >> 23927330

Variability of tumor area measurements for response assessment in malignant pleural mesothelioma.

Zacariah E Labby1, Christopher Straus, Philip Caligiuri, Heber MacMahon, Ping Li, Alexandra Funaki, Hedy L Kindler, Samuel G Armato.   

Abstract

PURPOSE: The measurement of malignant pleural mesothelioma is critical to the assessment of tumor response to therapy. Current response assessment standards utilize summed linear measurements acquired on three computed tomography (CT) sections. The purpose of this study was to evaluate manual area measurements as an alternate response assessment metric, specifically through the study of measurement interobserver variability.
METHODS: Two CT scans from each of 31 patients were collected. Using a computer interface, five observers contoured tumor on three selected CT sections from each baseline scan. Four observers also constructed matched follow-up scan tumor contours for the same 31 patients. Area measurements extracted from these contours were compared using a random effects analysis of variance model to assess relative interobserver variability. The sums of section area measurements were also analyzed, since these area sums are more clinically relevant for response assessment.
RESULTS: When each observer's measurements were compared with those of the other four observers, strong correlation was observed. The 95% confidence interval for relative interobserver variability of baseline scan summed area measurements was [-71%, +240%], spanning 311%. For the follow-up scan summed area measurements, the 95% confidence interval for relative interobserver variability was [-41%, +70%], spanning 111%. At both baseline and follow-up, the variability among observers was a significant component of the total variability in both per-section and summed area measurements (p<0.0001).
CONCLUSIONS: Despite the ability of tumor area measurements to capture tumor burden with greater fidelity than linear tumor thickness measurements, manual area measurements may not be a robust means of response assessment in mesothelioma patients.

Entities:  

Mesh:

Year:  2013        PMID: 23927330      PMCID: PMC3739828          DOI: 10.1118/1.4810940

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  13 in total

1.  The influence of initial outlines on manual segmentation.

Authors:  William F Sensakovic; Adam Starkey; Rachael Roberts; Christopher Straus; Philip Caligiuri; Masha Kocherginsky; Samuel G Armato
Journal:  Med Phys       Date:  2010-05       Impact factor: 4.071

2.  Discrete-space versus continuous-space lesion boundary and area definitions.

Authors:  William F Sensakovic; Adam Starkey; Rachael Y Roberts; Samuel G Armato
Journal:  Med Phys       Date:  2008-09       Impact factor: 4.071

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans.

Authors:  Fan Liu; Binsheng Zhao; Lee M Krug; Nicole M Ishill; Remy C Lim; Pingzhen Guo; Matthew Gorski; Raja Flores; Chaya S Moskowitz; Valerie W Rusch; Lawrence H Schwartz
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

5.  Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma.

Authors:  H I Pass; B K Temeck; K Kranda; S M Steinberg; I R Feuerstein
Journal:  J Thorac Cardiovasc Surg       Date:  1998-02       Impact factor: 5.209

6.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

7.  Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.

Authors:  Samuel G Armato; Geoffrey R Oxnard; Heber MacMahon; Nicholas J Vogelzang; Hedy L Kindler; Masha Kocherginsky; Adam Starkey
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

8.  Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.

Authors:  M J Byrne; A K Nowak
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

9.  Variability in mesothelioma tumor response classification.

Authors:  Samuel G Armato; Joseph L Ogarek; Adam Starkey; Nicholas J Vogelzang; Hedy L Kindler; Masha Kocherginsky; Heber MacMahon
Journal:  AJR Am J Roentgenol       Date:  2006-04       Impact factor: 3.959

10.  Disease volumes as a marker for patient response in malignant pleural mesothelioma.

Authors:  Z E Labby; A K Nowak; J J Dignam; C Straus; H L Kindler; S G Armato
Journal:  Ann Oncol       Date:  2012-11-08       Impact factor: 32.976

View more
  5 in total

Review 1.  Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications.

Authors:  Kaustav Bera; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Am Soc Clin Oncol Educ Book       Date:  2018-05-23

2.  Deep learning-based segmentation of malignant pleural mesothelioma tumor on computed tomography scans: application to scans demonstrating pleural effusion.

Authors:  Eyjolfur Gudmundsson; Christopher M Straus; Feng Li; Samuel G Armato
Journal:  J Med Imaging (Bellingham)       Date:  2020-01-29

3.  Deep convolutional neural networks for the automated segmentation of malignant pleural mesothelioma on computed tomography scans.

Authors:  Eyjolfur Gudmundsson; Christopher M Straus; Samuel G Armato
Journal:  J Med Imaging (Bellingham)       Date:  2018-09-24

4.  Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.

Authors:  Darragh Halpenny; Micheal Raj; Andreas Rimner; Junting Zheng; Marinela Capanu; Michelle S Ginsberg
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

5.  Radiomics in lung cancer for oncologists.

Authors:  Carolina de la Pinta; Nuria Barrios-Campo; David Sevillano
Journal:  J Clin Transl Res       Date:  2020-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.